How animal models can be utilized to find new biomarkers for cardiovascular diseases.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 527, doi. 10.1042/CS20220832
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2023 AND VI 137 AND IP 6
Results: 8
1
2
Cardioprotective and anti-inflammatory effects of Caveolin 1 in experimental diabetic cardiomyopathy.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 511, doi. 10.1042/CS20220874
- By:
- Publication type:
- Article
3
CircRBM23 regulates the switch between osteogenesis and adipogenesis of mesenchymal stem cells via sponging miR-338-3p.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 495, doi. 10.1042/CS20220833
- By:
- Publication type:
- Article
4
By what molecular mechanisms do social determinants impact cardiometabolic risk?
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 489, doi. 10.1042/CS20220304
- By:
- Publication type:
- Article
5
Ferredoxin 1 regulates granulosa cell apoptosis and autophagy in polycystic ovary syndrome.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 453, doi. 10.1042/CS20220408
- By:
- Publication type:
- Article
6
Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 435, doi. 10.1042/CS20220728
- By:
- Publication type:
- Article
7
Hormonal regulation of metabolism--recent lessons learned from insulin and estrogen.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 415, doi. 10.1042/CS20210519
- By:
- Publication type:
- Article
8
Neurochemical effects of sepsis on the brain.
- Published in:
- Clinical Science, 2023, v. 137, n. 6, p. 401, doi. 10.1042/CS20220549
- By:
- Publication type:
- Article